Humoral immune response to an mRNA-1273 booster after chAdOx1-nCoV-19-priming among patients undergoing hemodialysis

OBJECTIVES: Patients who are undergoing dialysis due to end-stage kidney disease are susceptible to greater coronavirus disease 2019 (COVID-19) complications. While vaccination is seen as the most effective tactic against COVID-19, the dialysis population usually has impaired immune responses to vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Bo-Yu, Lin, Ting-Yun, Hung, Szu-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683517/
https://www.ncbi.nlm.nih.gov/pubmed/38035061
http://dx.doi.org/10.4103/tcmj.tcmj_107_23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683517/
https://www.ncbi.nlm.nih.gov/pubmed/38035061
http://dx.doi.org/10.4103/tcmj.tcmj_107_23

Ejemplares similares